Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Journal1
- Article Type
- Review1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Drugs1
Search Results
Sort by
- Bookeditor, Jonathan C. Cho.Summary: "The goal of Infectious Diseases: A Case Study Approach is to provide healthcare students with a valuable infectious diseases pharmacotherapy resource. With the growing need of antimicrobial stewardship programs, healthcare professionals competent in infectious diseases pharmacotherapy are necessary. The casebook is designed to teach infectious diseases through patient cases that closely resemble situations healthcare professionals will likely face during their clinical practice. Infectious diseases-related topics covered in the publication range from bacterial infections, to sexually transmitted diseases, to antimicrobial dosing recommendations. Topics were selected based on the Accreditation Council for Pharmacy Education's Coding Systems for Colleges of Pharmacy and the 2016 American College of Clinical Pharmacy's Pharmacotherapy Didactic Curriculum Toolkit. Authors of the casebook chapters are comprised of infectious diseases pharmacist faculty from Colleges of Pharmacy across the United States. All these individuals have vast experiences and training in infectious diseases and are widely recognized as experts in their field"-- Provided by publisher.Digital Access AccessPharmacy 2020
- ArticleBrogden RN, Heel RC, Speight TM, Avery GS.Drugs. 1978 Oct;16(4):273-301.Mianserin is a tetracyclic compound advocated for the treatment of depressive illness and depression associated with anxiety. It combines antidepressant activity with a sedative effect and has an EEG and clinical activity profile similar to that of amitriptyline. It has an overall efficacy comparable with amitriptyline and imipramine in depressive illness, but at dosages which have achieved a similar overall clinical improvement, mianserin causes significantly fewer anticholinergic side effects than amitriptyline or imipramine and also appears less likely than these drugs to cause serious cardiotoxicity on overdosage. Mianserin also has anti-anxiety activity, but its role in treating patients with anxiety associated with primary depression has still to be clarified. Mianserin appears to be well tolerated by the elderly and by patients with cardiovascular disease, including those recovering from a recent myocardial infarction, and does not appear to antagonise the action of adrenergic neurone blocking antihypertensive drugs or affect the anticoagulant action of phenprocoumon.